Clinical observation study of 5-year survivals in patients with newly diagnosed acute lymphoblastic leukemia (ALL) in Japan Adult Leukemia Study Group (JALSG). (JALSG-ALL-CS-12)

Clinical observation study of 5-year survivals in patients with newly diagnosed acute lymphoblastic leukemia (ALL) in Japan Adult Leukemia Study Group (JALSG). (JALSG-ALL-CS-12) - JALSG ALL clinical observation study 12 (JALSG-ALL-CS-12)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007653

Enrollment

733

Registered

2012-04-03

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lymphoblastic leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Previously untreated ALL

Exclusion criteria

Exclusion criteria: Past history of chemotherapy or stem cell transplantation in the treatment of ALL

Design outcomes

Primary

Measure	Time frame
(1) ALL patient 5-year survivals (2) Effect of stem cell transplantation (SCT) on ALL patients (3) Effect of timing of SCT and conditioning regimen on ALL patients (4) Numbers of patients with ALL by age group, sex and type of diseases (5) Feasibility of classification according to known prognostic factors (6) Description of patients' status in chemotherapy program (7) Remission duration due to chemotherapy	—

Measure

Time frame

(1) ALL patient 5-year survivals (2) Effect of stem cell transplantation (SCT) on ALL patients (3) Effect of timing of SCT and conditioning regimen on ALL patients (4) Numbers of patients with ALL by age group, sex and type of diseases (5) Feasibility of classification according to known prognostic factors (6) Description of patients' status in chemotherapy program (7) Remission duration due to chemotherapy

—

Countries

Japan

Contacts

Public ContactYoshihiro Hatta

JALSG-ALL-CS-12 research secretariat Hematology and Rheumatology, Nihon University School of Medicine

hatta.yosihiro@nihon-u.ac.jp03-3972-8111

Outcome results